Key result
Postload 1-hour glucose ≥/dL is strongly linked to higher all-cause mortality in normal glucose tolerance.
Why the study?
Does 1-hour postload plasma glucose ≥170 mg/dL predict all-cause mortality in subjects with normal glucose tolerance?
Cohort (n=993)
Does 1-hour postload plasma glucose ≥170 mg/dL predict all-cause mortality in subjects with normal glucose tolerance?
Answers are grounded in this paper and cite their sources.
A 1-hour postload glucose level ≥170 mg/dL during an OGTT is a strong predictor of future all-cause, cardiovascular, and cancer mortality even in subjects with normal glucose tolerance.
Little is known about biological markers, at levels within their normal ranges which might predict future mortality. We aimed at identifying possible predictors of future death in participants before pathological conditions manifest. We analyzed data from a population-based prospective cohort study (the Ohasama study), comprised of 993 participants who underwent 75-g oral glucose tolerance tests (OGTTs). We collected blood parameters, including those measured during OGTTs, and divided the study population into two groups based on the median value of each parameter, followed by analyses of mortality during follow-up in both groups. In addition, we extracted subjects with normal glucose tolerance (NGT) (n = 595) and analyzed the association between 1-h postload plasma glucose during OGTTs (1-hrPG) and mortality as well as the causes of death. Among all parameters evaluated, 1-hrPG was found to be most significantly associated with all-cause mortality during the mean follow-up of 14.3 years. When we focused on subjects with NGT, Harrell's C concordance index analysis revealed a cut-off of 1-hrPG ≥170 mg/dL to be most strongly associated with all-cause mortality (0.8066). The Kaplan–Meier plots showed nearly double the proportion of the 1-hrPG ≥170 group to have died as compared with the 1-hrPG <170 group throughout the follow-up period after the third year. Cardiovascular diseases and malignant neoplasms both strongly contributed to the increased mortality in the high 1-hrPG group. Thus, 1-hrPG ≥170 is a powerful predictor of future death in subjects with NGT. Atherosclerotic and malignant diseases both contributed to the increased mortality.
No takes yet. Share an insight, caveat, or question.
Sato et al. (2025) conducted a cohort in Healthy subjects (n=993). 1-hour postload plasma glucose ≥170 mg/dL vs. 1-hour postload plasma glucose <170 mg/dL was evaluated on All-cause mortality (C-index 0.8066). In subjects with normal glucose tolerance, a 1-hour postload plasma glucose ≥/dL was strongly associated with all-cause mortality over a mean follow-up of 14.3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: